Showing results (511-520 of 894) with videos related to

Sort By:
Pageof 90
Diabetologia|March 31, 2012
Xylitol prevents NEFA-induced insulin resistance in ratsP Kishore, S Kehlenbrink, M Hu, et al.
The American Journal of Cardiology|May 16, 2015
Review of eligibility for cardiac resynchronization therapyNathaniel M Hawkins, Matthew T Bennett, Jason G Andrade, et al.
Atherosclerosis|March 22, 2005
Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry studyH A W Neil, M M Hawkins, P N Durrington, et al.
Annals of Emergency Medicine|July 30, 2021
Impact of Atrial Fibrillation Case Volume in the Emergency Department on Early and Late Outcomes of Patients With New Atrial FibrillationNathaniel M Hawkins, Erik Youngson, Roopinder K Sandhu, et al.
Organic & Biomolecular Chemistry|January 21, 2015
Cyclopropanation using flow-generated diazo compoundsNuria M Roda, Duc N Tran, Claudio Battilocchio, et al.
Mbio|July 1, 2025
Deciphering cell cycle organization of Toxoplasma endodyogenyMrinalini Batra, Clem Marsilia, Danya Awshah, et al.
BMC Pediatrics|April 20, 2020
Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative studyLauren M Hawkins, Cynthia B Sinha, Diana Ross, et al.
Cancer Genetics and Cytogenetics|October 15, 1993
Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemiaL M Secker-Walker, J M Hawkins, H G Prentice, et al.
The Journal of Organic Chemistry|January 1, 1990
Organic chemistry of C60 (Buckminsterfullerene): chromatography and osmylationJ M Hawkins, T A Lewis, S D Loren, et al.
Atherosclerosis|September 6, 2003
Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry studyH A W Neil, R R Huxley, M M Hawkins, et al.
Pageof 90